When Tirtha first joined PHARMASEAL, he wasn’t just looking for a new job - he was seeking a mission. Having experienced the inertia of larger corporations, he was looking for an environment that was agile, innovative, and serving a greater purpose in healthcare. “To truly drive meaningful change,” he explains, “I sought an agile environment, free from legacy constraints, where I could leverage technology for social good.” That’s exactly what he found at PHARMASEAL.

From day one, Tirtha was struck by the team’s relentless drive: “What truly impresses me is the team’s exceptional work ethic. Their focus and dedication allow them to achieve remarkable results with a lean team.” It’s an impressively high-performing team where collaboration is a core value, not just a corporate cliché. He describes the team dynamic in three simple but powerful words: partnership, trust, and accountability.

Tirtha’s time at PHARMASEAL has also shifted his view of the pharmaceutical industry. The rise of AI and personalised medicine, he says, is not just theoretical - it’s happening now. “AI’s ability to analyse extensive data, pinpoint targets, and forecast patient reactions is driving significant progress,” he notes. And it’s not just the technology that’s evolving, it’s the mindset. “The industry’s commitment to personalised medicine, driven by genetic makeup, lifestyle, and social mobility, is poised to optimise treatment outcomes.”

Yet, in an era where AI and technology often face criticism for their potential to cause harm, it’s important to acknowledge the positive strides being made. Much of the focus is on the damage certain technologies have caused, but Tirtha’s work at PHARMASEAL tells a different story, one where technology is a force for good. By revolutionising clinical trials and improving outcomes, the industry has the potential to positively impact patient lives in meaningful ways. Tirtha’s role in using cloud-based solutions and driving technological progress proves that innovation can and should have a lasting, positive effect on society. As he continues to push the boundaries of what’s possible in clinical research, Tirtha hopes to inspire others to harness technology for social good, improving lives along the way.

Engility® Connect, a serverless integration platform that Tirtha helped build is a direct result of that forward-thinking vision. He led its creation with a focus on automation and scalability, designing a proprietary technology that eliminates the need for repetitive, study-by-study integration. “It delivers substantial cost savings and unlocks powerful downstream data analytics,” he explains, ensuring clinical trial data is consistent, timely, and accurate.

But meaningful moments aren’t always tied to major achievements. For Tirtha, it was a small gesture of recognition that stood out: “I presented a new cost optimisation idea, and afterwards, my manager personally thanked me after it was implemented. That small gesture of recognition was incredibly inspiring.” It’s moments like these that reinforce a culture of appreciation and growth.

PHARMASEAL, he says, stands apart in many ways, but perhaps most notably in its humility and drive for excellence. “We recognise that technical solutions are always evolving. That’s why we cultivate a culture of humility and relentlessly pursue excellence.”

It’s also a place where personal growth is actively supported. Whether it’s attending conferences, diving into research papers, or sharing online courses with peers, the company ensures everyone stays ahead of the curve. Along the way, Tirtha has picked up unexpected skills, like learning to “listen without judgement and respond with empathy.”

For those considering a career in clinical trial technology, Tirtha offers a clear-eyed piece of advice: “Build a solid foundation in both technology and clinical research principles. Understand GCP, standards like CDISC, and cultivate a mindset of continuous learning. There’s a profound satisfaction in contributing to software that enables life-changing therapies.”

Tirtha wants to clear up a common misunderstanding: that cutting-edge clinical trial tech is only for big pharma. “Smaller companies often assume it’s too complex or expensive,” he says. “But thanks to cloud-based solutions, that’s no longer the case - today, the playing field is more level than ever.”

Tirtha’s experience highlights how the right environment can turn ambition into meaningful change. If PHARMASEAL had a company playlist, Tirtha’s picks would embody the spirit of ambition, innovation, and resilience that drives both his journey and the company’s mission. From Coldplay’s “A Sky Full of Stars” to Queen’s “We Are the Champions,” it’s a playlist that mirrors a team always striving to do more and aim higher.

We think that what stands out most in Tirtha’s story isn’t just what he’s achieved - but why he chose to do it here.